Cargando…
Detection of YMDD Motif Mutants by Oligonucleotide Chips in Lamivudine-Untreated Patients with Chronic Hepatitis B Virus Infection
Lamivudine, a nucleoside analogue, has been used widely as an effective antiviral agent for the treatment of patients with chronic hepatitis B virus (HBV) infection. However, the YMDD motif mutation of HBV polymerase resistant to lamivudine occurs very frequently after long term therapy. We develope...
Autores principales: | Heo, Jeong, Cho, Mong, Kim, Hyung Hoi, Shin, Young Min, Jang, Hyun Jung, Park, Hee Kyung, Kim, Cheol Min, Kim, Gwang Ha, Kang, Dae Hwan, Song, Geun Am, Yang, Ung Suk |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2816888/ https://www.ncbi.nlm.nih.gov/pubmed/15308845 http://dx.doi.org/10.3346/jkms.2004.19.4.541 |
Ejemplares similares
-
YMDD motif mutation after lamivudine therapy
por: Jazayeri, Seyed Mohammad, et al.
Publicado: (2011) -
Probing rate of YMDD motif mutant in lamivudine treatment of Iranian patients with chronic hepatitis B virus infection
por: Ghandehari, Freshte, et al.
Publicado: (2011) -
The Naturally Occurring YMDD Mutation among Patients Chronically Infected HBV and Untreated with Lamivudine: A Systematic Review and Meta-Analysis
por: Tan, Youwen, et al.
Publicado: (2012) -
The Clinical Value of Oxymatrine in Preventing Lamivudine Induced YMDD Mutation: A Meta-Analysis
por: He, Min, et al.
Publicado: (2015) -
Viral quasispecies of hepatitis B virus in patients with YMDD mutation and lamivudine resistance may not predict the efficacy of lamivudine/adefovir rescue therapy
por: Wang, Changtai, et al.
Publicado: (2019)